LUNG TRANSPLANT REJECTION

Clinical trials for LUNG TRANSPLANT REJECTION explained in plain language.

Never miss a new study

Get alerted when new LUNG TRANSPLANT REJECTION trials appear

Sign up with your email to follow new studies for LUNG TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Completed 2 Terminated 2

New drug aimed at stopping lung rejection in transplant patients

Disease control Not yet recruiting

This early-stage trial tests a drug called fostamatinib in 30 adults who have developed donor-specific antibodies after a lung transplant. These antibodies can attack the new lung and raise the risk of death. Participants take fostamatinib or a placebo for 8 weeks, along with the…

Matched conditions: LUNG TRANSPLANT REJECTION

Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jul 02, 2026 03:00 UTC

LUNG TRANSPLANT REJECTION

Get alerted when new LUNG TRANSPLANT REJECTION trials appear

New drug aimed at stopping lung rejection in transplant patients